Medical News: Drug Takes 'Thrill' Out of Kleptomania - in Psychiatry, Addictions from MedPage Today

Links shared publicly online about this topic.

  • 2,145
    total visits

Medical News: Drug Takes 'Thrill' Out of Kleptomania - in Psychiatry, Addictions from MedPage Today

medpagetoday.com

TORONTO -- A drug that takes the thrill out of stealing may be a useful treatment for kleptomania, researchers said.

View full resource at medpagetoday.com

Tags: Addiction, Drug, Psychiatry, Psychology

  • Share

Most Recently Shared on April 2, 2009 at 12:07 pm By:

MichaelLaraMD Michael Lara, MD

"Drug Takes "Thrill" Out of Kleptomania." http://bit.ly/3Xe3gB

3 years ago...

Medical News: Phone Calls Boost Drug Adherence After Stenting - in Meeting Coverage, SCAI from MedPage Today

medpagetoday.com — “Medical News: Phone Calls Boost Drug Adherence After Stenting - in Meeting Coverage, SCAI from MedPage TodayView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on May 11, 2012 at 7:01 pm By:

Medical News: Pfizer's Arthritis Pill Gets Nod from FDA Panel - in Rheumatology, Arthritis from MedPage Today

medpagetoday.com — “Medical News: Pfizer's Arthritis Pill Gets Nod from FDA Panel - in Rheumatology, Arthritis from MedPage TodayView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on May 10, 2012 at 1:10 pm By:

FDA Takes Steps to Lower Kids’ Radiation Exposure - ABC News

abcnews.go.com — “In an effort to make sure that kids don’t get too much radiation during medical tests, the U.S. Food and Drug Administration  proposed guidelines for manufacturers of medical imaging devices to make  new equipment that takes children’s safety into account. The agency is urging manufacturers to include instructions on how to safely use their devices in pediatric settings.  If device makers can’t prove their machines are safe and effective for use on children,View full resource at abcnews.go.com

  • View Related
  • Share

Most Recently Shared on May 9, 2012 at 9:42 pm By:

DrHubaEvaluator George Huba, Ph.D. Psychologist, PhD, and Doctor

FDA Takes Steps to Lower Kids' Radiation Exposure - In an effort to make sure that kids don’t get too much radiation... http://t.co/rCyAWkOi

3 weeks ago...

Probiotics may help prevent diarrhea: report - Yahoo! News

news.yahoo.com — “From Yahoo! News: NEW YORK (Reuters Health) - Taking probiotics on top of a course of antibiotics may help ward off the diarrhea that often comes along with antibiotic treatment, a new review of past studies suggests. When researchers combined trials of all types of the gut-healthy microbes, they found that patients with a range of conditions -- from ear infections to sepsis -- were 42 percent less likely to get diarrhea from their antibiotic drugs if they were also taking a probiotic. One-quartView full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on May 9, 2012 at 12:43 am By:

Ear_Nose_Throat Ear, Nose, and Throat OW Health

Probiotics may help prevent diarrhea: report: NEW YORK (Reuters Health) - Taking probiotics on top of a course o... http://t.co/EU4QIO12

3 weeks ago...

Medical News: Data Inconclusive for Oral Arthritis Drug - in Rheumatology, Arthritis from MedPage Today

medpagetoday.com — “Medical News: Data Inconclusive for Oral Arthritis Drug - in Rheumatology, Arthritis from MedPage TodayView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on May 8, 2012 at 7:53 pm By:

Medical News: Docs May Resist PSA Screening Recommendations - in Oncology/Hematology, Prostate Cancer from MedPage Today

medpagetoday.com — “Medical News: Docs May Resist PSA Screening Recommendations - in Oncology/Hematology, Prostate Cancer from MedPage TodayView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on May 8, 2012 at 2:15 am By:

kussin49 Dr. Steven Z. Kussin Doctor, Internist, Gastroenterologist, and Physician

PSA testing. "The chains of habit are too weak to be felt until they are too strong to be broken." You take the... http://t.co/srUs9sTq

3 weeks ago...

Drug-Defying Germs From India Speed Post-Antibiotic Era - Bloomberg

bloomberg.com — “Lill-Karin Skaret, a 67-year-old grandmother from Namsos, Norway, was traveling to a lakeside vacation villa near India’s port city of Kochi in March 2010 when her car collided with a truck. She was rushed to the Amrita Institute of Medical Sciences, her right leg broken and her artificial hip so damaged that replacing it required 12 hours of surgery.View full resource at bloomberg.com

  • View Related
  • Share

Most Recently Shared on May 7, 2012 at 11:51 pm By:

FiercePharma FiercePharma Health Site

RT @BloombergNews: Drug-defying germs from India speed post-antibiotic era | http://t.co/LrOwFvjk

3 weeks ago...

Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets

newswise.com — “A new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximately one quarter of patients with low platelet counts and a risk of bleeding due to chronic immune thrombocytopenic purpura (ITP). In study results published online today in Blood, the Journal of the American Society of Hematology (ASH), investigators at Weill Cornell Medical College provide the very first long-term outcome data for patients wView full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on May 7, 2012 at 4:44 pm By:

mednewswise Thom Canalichio Health News

#health news: Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets http://t.co/ebFOkm4e

3 weeks ago...

Smith & Nephew eyes Brazil as $150 million market | Wall Street Beat | MassDevice - Medical Device Industry News

massdevice.com — “Smith & Nephew looks to increase business in Brazil 7-fold; Masimo eyes a pair of acquisitions; St. Jude takes $70 million restructuring charge during Q1; plus, a Funding Roundup and analysts' ups and downs.View full resource at massdevice.com

  • View Related
  • Share

Most Recently Shared on May 7, 2012 at 3:48 pm By:

alana_ngo Alana Ngo Nurse

Smith & Nephew eyes Brazil as $150 million market | Wall Street Beat | MassDevice - Medical Device Industry News http://t.co/KHOvvZ42

3 weeks ago...

Ventana granted FDA clearance for Companion Algorithm p53 (DO-7) image analysis application

news-medical.net — “Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 7, 2012 at 1:48 pm By:

NewsMedical News-Medical.Net Health News

Ventana granted FDA clearance for Companion Algorithm p53 (DO-7) image analysis application: Ventana Medical Sys... http://t.co/6MCZ4tuc

3 weeks ago...

Medical News: DC Week: NIH, Pharma Join Forces - in Washington-Watch, Washington Watch from MedPage Today

medpagetoday.com — “Medical News: DC Week: NIH, Pharma Join Forces - in Washington-Watch, Washington Watch from MedPage TodayView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on May 6, 2012 at 12:01 am By:

HealthTrendster HealthTrendster Health Executive

DC Week: NIH, Pharma Join Forces: WASHINGTON (MedPage Today) -- The National Institutes of… http://t.co/7Auf2M0c

4 weeks ago...

Medical News: Ex Vivo Surgery Works on Complex Tumors - in Surgery, General Surgery from MedPage Today

medpagetoday.com — “Medical News: Ex Vivo Surgery Works on Complex Tumors - in Surgery, General Surgery from MedPage TodayView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on May 5, 2012 at 7:38 am By:

Gastro_Digestiv OrganizedWisdom GI OW Health

Ex Vivo Surgery Works on Complex Tumors (CME/CE): (MedPage Today) -- Multivisceral ex vivo surgery appears to be... http://t.co/NUvExhOo

4 weeks ago...

Preview: U.S. panel seen backing Pfizer's arthritis drug hope - Yahoo! News

news.yahoo.com — “From Yahoo! News: WASHINGTON (Reuters) - Pfizer Inc's experimental rheumatoid arthritis drug goes before an advisory panel next week, a potential blockbuster medicine that would revive faith in the company's research if its benefits are deemed to outweigh its side effects. Most industry analysts expect the Food and Drug Administration's expert committee to recommend approval despite risks posed by higher-than-normal cholesterol and liver enzyme levels and infections for patients taking tofacitinView full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 12:10 pm By:

Arthritis_OW Arthritis OW Active Health Library and OW Health

Preview: U.S. panel seen backing Pfizer's arthritis drug hope: WASHINGTON (Reuters) - Pfizer Inc's experimental ... http://t.co/EuZGvdyn

4 weeks ago...

MIMS app updated to include tables | MIMS online

mims.co.uk — “The latest pharmaceutical, medical and drugs news on MIMS onlineView full resource at mims.co.uk

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 9:30 am By:

mimsonline MIMS Online Medical Publisher

The MIMS app provides info on >4000 medications, with free monthly updates. Watch a demo here: http://t.co/1SA2nEt6 #mobilehealth #healthapp

4 weeks ago...

Aveo takes 1Q loss as drug development continues - BusinessWeek

businessweek.com — “Aveo Pharmaceuticals Inc. said Thursday it took a loss in the first quarter as it continued development of two experimental cancer drugs.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 5:45 am By:

Drugs_Devices Drugs and Devices OW OW Health

Aveo takes 1Q loss as drug development continues - BusinessWeek: Updated NewsAveo takes 1Q loss as drug de... http://t.co/NyPVouhZ #drug

4 weeks ago...

Advertisement